Literature DB >> 10769700

Clinical significance of angiogenesis, proliferation and apoptosis in renal cell carcinoma.

S Yoshino1, M Kato, K Okada.   

Abstract

BACKGROUND: The prognostic significance of angiogenesis, proliferation and apoptosis after interferon (IFN) was investigated in 96 patients with renal cell carcinoma (RCC).
MATERIALS AND METHODS: Microvessel density in the tumor(MVD), proliferative index(PI) and apoptotic index(AI) were quantified using immunohistochemical staining of factor VIII-related antigen and Ki-67 antigen for the former two parameters and the TUNNEL technique for AI.
RESULTS: MVD and PI were correlated with the M criteria and histological grade. AI was not correlated with either criteria. Analysis using PI, AI, MVD and the classical prognostic factors revealed that PI was the most significant prognostic factor and that patients with high MVD values and those with low AI values had a poor prognosis. Of the high MVD group and high PI group among patients with metastasis, IFN-treated patients showed a tendency for a better prognosis than nontreated patients (p = 0.067 and 0.020, respectively).
CONCLUSIONS: It is speculated that proliferation, angiogenesis and apoptosis play a complex role in the prognosis of patients with RCC. It is suggested that IFN treatment is likely to have an inhibitory effect on proliferation and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10769700

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

1.  Expression of Pax2 in human renal tumor-derived endothelial cells sustains apoptosis resistance and angiogenesis.

Authors:  Valentina Fonsato; Stefano Buttiglieri; Maria Chiara Deregibus; Valeria Puntorieri; Benedetta Bussolati; Giovanni Camussi
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

2.  The vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor cediranib (Recentin; AZD2171) inhibits endothelial cell function and growth of human renal tumor xenografts.

Authors:  Dietmar W Siemann; W D Brazelle; Juliane M Jürgensmeier
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-01       Impact factor: 7.038

3.  Integrin-linked kinase (ILK) expression correlates with tumor severity in clear cell renal carcinoma.

Authors:  Míriam de Fátima Brasil Engelman; Rogério Mendes Grande; Marcelo Andery Naves; Marcello Fabiano de Franco; Vicente de Paulo Castro Teixeira
Journal:  Pathol Oncol Res       Date:  2012-07-20       Impact factor: 3.201

Review 4.  Prognostic role of microvessel density in patients with renal cell carcinoma: a meta-analysis.

Authors:  Si-Hang Cheng; Jia-Ming Liu; Qin-Yu Liu; De-Yi Luo; Bang-Hua Liao; Hong Li; Kun-Jie Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

5.  Association between microvessel density and histologic grade in renal cell carcinomas.

Authors:  Nikolaos Kavantzas; Helen Paraskevakou; Sofia Tseleni-Balafouta; Kyriaki Aroni; Pauline Athanassiades; George Agrogiannis; Efstratios Patsouris
Journal:  Pathol Oncol Res       Date:  2007-07-03       Impact factor: 3.201

6.  Increased expression of Chitinase 3-like 1 and microvessel density predicts metastasis and poor prognosis in clear cell renal cell carcinoma.

Authors:  Jian-Ping Zhang; Hai-Xia Yuan; Wen-Tao Kong; Yujun Liu; Zong-Ming Lin; Wen-Ping Wangs; Jian-Ming Guo
Journal:  Tumour Biol       Date:  2014-08-21

7.  In vivo assessment of the antiproliferative properties of interferon-alpha during immunotherapy: Ki-67 (MIB-1) in patients with metastatic renal cell carcinoma.

Authors:  F Donskov; N Marcussen; M Hokland; R Fisker; H H T Madsen; H von der Maase
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

Review 8.  Novel concepts in the staging of renal cell carcinoma.

Authors:  Dan Leibovici; Arie Lindner; Avishay Sella; Amnon Zisman
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 2.862

9.  Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients.

Authors:  T Itoi; K Yamana; V Bilim; K Takahashi; F Tomita
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

10.  Inhibition of renal cell carcinoma angiogenesis and growth by antisense oligonucleotides targeting vascular endothelial growth factor.

Authors:  W Shi; D W Siemann
Journal:  Br J Cancer       Date:  2002-07-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.